Volume 21, Issue 6 (12-2018)
J Arak Uni Med Sci 2018, 21(6): 14-25 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bagheri-Mohammadi S, Alani B, Noureddini M. Evaluation of Intranasal Delivery of Human Endometrial Stem Cells to the Substantia Nigra and Their Therapeutic Effects on Rotational Behavior Recovery in Mice Model of Parkinson's Disease. J Arak Uni Med Sci 2018; 21 (6) :14-25
URL: http://jams.arakmu.ac.ir/article-1-5774-en.html
URL: http://jams.arakmu.ac.ir/article-1-5774-en.html
1- Department of Physiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
2- Department of Applied Cell Sciences, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
3- Physiology Research Centre, Department of Applied Cell Sciences, Kashan University of Medical Sciences, Kashan, Iran. , mnoureddini@kaums.ac.ir
2- Department of Applied Cell Sciences, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
3- Physiology Research Centre, Department of Applied Cell Sciences, Kashan University of Medical Sciences, Kashan, Iran. , mnoureddini@kaums.ac.ir
Abstract: (2538 Views)
Background and Aim: Recent findings in cell therapy have presented new perspectives and opportunities for the treatment of neurodegenerative disease. The experimental research with intranasal (IN) administration of Stem Cells in Parkinson’s disease (PD) mouse model can work and in some cases induce major, long-lasting improvement. Adult Human endometrial derived stem cells (HEDSCs), a readily obtainable type of mesenchymal stem-like cell were used to generate dopaminergic cells and for cell therapy. In this study, we investigated the therapeutic effects of IN-delivered HEDSCs in mice model of Parkinson.
Materials and Methods: In this experimental research, 35 male mouse weighting 25-30 g were divided into 5 groups. On day 120 post cell administration, the rotational behavior was measured. Immunohistochemistry staining was used to detect HEDSCs in mice brain.
Findings: IN application of HEDSCs resulted in the appearance of cells in the substantia nigra (SN) and decrease in the rotational behavior of case group.
Conclusion: HEDSCs are a highly inducible source of allogenic stem cells that improve Parkinson’s disease.
Materials and Methods: In this experimental research, 35 male mouse weighting 25-30 g were divided into 5 groups. On day 120 post cell administration, the rotational behavior was measured. Immunohistochemistry staining was used to detect HEDSCs in mice brain.
Findings: IN application of HEDSCs resulted in the appearance of cells in the substantia nigra (SN) and decrease in the rotational behavior of case group.
Conclusion: HEDSCs are a highly inducible source of allogenic stem cells that improve Parkinson’s disease.
References
1. Pakkenberg B, Møller A, Gundersen H, Dam AM, Pakkenberg H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. Journal of Neurology, Neurosurgery & Psychiatry. 1991; 54(1):30-3.
2. Levy G, Tang M-X, Louis ED, Cote LJ, Alfaro B, Mejia H, et al. The association of incident dementia with mortality in PD. Neurology. 2002; 59(11):1708-13.
3. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature. 2006; 441(7097):1094.
4. Barker RA, Barrett J, Mason SL, Björklund A. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease. The Lancet Neurology. 2013; 12(1):84-91.
5. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nature medicine. 2002; 8(10):1115.
6. Kim C, Lee HC, Sung J-J. Amyotrophic lateral sclerosis-cell based therapy and novel therapeutic development. Experimental neurobiology. 2014; 23(3):207-14.
7. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003; 39(6):889-909.
8. Blesa J, Phani S, Jackson-Lewis V, Przedborski S. Classic and new animal models of Parkinson's disease. BioMed Research International. 2012; 2012.
9. Nam H, Lee K-H, Nam D-H, Joo KM. Adult human neural stem cell therapeutics: Current developmental status and prospect. World journal of stem cells. 2015; 7(1):126.
10. Ikegame Y, Yamashita K, Nakashima S, Nomura Y, Yonezawa S, Asano Y, et al. Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke? Frontiers in cellular neuroscience. 2014; 8:322.
11. Kitada M, Dezawa M. Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy. Parkinson’s disease. 2012; 2012.
12. Sundberg M, Isacson O. Advances in stem-cell–generated transplantation therapy for Parkinson's disease. Expert opinion on biological therapy. 2014; 14(4):437-53.
13. Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing research reviews. 2006; 5(1):91-116.
14. Vishnubalaji R, Al-Nbaheen M, Kadalmani B, Aldahmash A, Ramesh T. Comparative investigation of the differentiation capability of bone-marrow-and adipose-derived mesenchymal stem cells by qualitative and quantitative analysis. Cell and tissue research. 2012; 347(2):419-27.
15. Bellantuono I, Aldahmash A, Kassem M. Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2009; 1792(4):364-70.
16. Dvorakova J, Hruba A, Velebny V, Kubala L. Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets. Cell biology international. 2008; 32(9):1116-25.
17. Ghobadi F, Mehrabani D, Mehrabani G. Regenerative potential of endometrial stem cells: a mini review. World journal of plastic surgery. 2015; 4(1):3.
18. Wolff EF, Mutlu L, Massasa EE, Elsworth JD, Eugene Redmond D, Taylor HS. Endometrial stem cell transplantation in MPTP‐exposed primates: an alternative cell source for treatment of Parkinson's disease. Journal of cellular and molecular medicine. 2015; 19(1):249-56.
19. Verdi J, Tan A, Shoae-Hassani A, Seifalian AM. Endometrial stem cells in regenerative medicine. Journal of Biological Engineering. 2014; 8(1):20.
20. Shoae‐Hassani A, Sharif S, Seifalian AM, Mortazavi‐Tabatabaei SA, Rezaie S, Verdi J. Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women. BJU international. 2013; 112(6):854-63.
21. Noureddini M, Verdi J, Mortazavi‐Tabatabaei SA, Sharif S, Azimi A, Keyhanvar P, et al. Human endometrial stem cell neurogenesis in response to NGF and bFGF. Cell biology international. 2012; 36(10):961-6.
22. Kozłowska H, Jabłonka J, Janowski M, Jurga M, Kossut M, Domańska-Janik K. Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem cells and development. 2007; 16(3):481-8.
23. Yang B, Migliati E, Parsha K, Schaar K, Xi X, Aronowski J, et al. Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke. 2013; 44(12):3463-72.
24. Fransson M, Piras E, Wang H, Burman J, Duprez I, Harris RA, et al. Intranasal delivery of central nervous system‐retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis. Immunology. 2014; 142(3):431-41.
25. Danielyan L, Beer-Hammer S, Stolzing A, Schäfer R, Siegel G, Fabian C, et al. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease. Cell transplantation. 2014; 23(1):S123-S39.
26. Vahidinia Z, Alipour N, Atlasi MA, Naderian H, Beyer C, Azami Tameh A. Gonadal steroids block the calpain-1-dependent intrinsic pathway of apoptosis in an experimental rat stroke model. Neurological research. 2017; 39(1):54-64.
27. Lee S, Choi E, Cha M-J, Hwang K-C. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy. Oxidative medicine and cellular longevity. 2015; 2015.
28. Wolff EF, Gao XB, Yao KV, Andrews ZB, Du H, Elsworth JD, et al. Endometrial stem cell transplantation restores dopamine production in a Parkinson’s disease model. Journal of cellular and molecular medicine. 2011; 15(4):747-55.
29. Dhanda DS, Frey W, Leopold D, Kompella UB. Approaches for drug deposition in the human olfactory epithelium. Drug Deliv Technol. 2005; 5(4):64-72.
30. Darzi S, Werkmeister JA, Deane JA, Gargett CE. Identification and characterization of human endometrial mesenchymal stem/stromal cells and their potential for cellular therapy. Stem cells translational medicine. 2016; 5(9):1127-32.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
